Archive for January, 2016

No Cell Left Behind

| January 31, 2016 | 1 Comment

Interesting article by Kathy Liszewski over at Genetic Engineering and Biotechnology News looking at circulating tumor cells (CTCs) incorporated with digital pathology. There is little doubt in my mind that technologies involving CTCs, liquid biopsy (see my thoughts from ASCO 2015) and digital pathology are going to converge.  The ability to identify individual cells and specific […]

Continue Reading

Why Can’t Medicine Be More Like Uber?

| January 28, 2016 | 5 Comments

Anyone who has used Uber would probably use terms such as “easy”, “fast”, “simple”, “transparent”, or “cost-effective”. Uber, and for the sake of argument, let’s say other ride share services, allows for people who need a ride and people who can provide that ride a mechanism in a very transparent, open-market system to connect and […]

Continue Reading

Register Now for Digital Pathology Conference in San Francisco and Save

| January 27, 2016 | 0 Comments

Fourth Annual Digital Pathology Transforming Medicine in a Digital World March 7-9, 2016   |   Moscone North Convention Center   |   San Francisco, CA Part of the 23rd Annual Molecular Medicine Tri-Conference Triconference.com/Digital-Pathology Deadline this Friday for CHI’s Fourth Annual Digital Pathology Conference Join 3,000+ Informatics, Diagnostics, Clinical and Oncology Researchers in San Francisco  The Fourth Annual Digital […]

Continue Reading

OracleBio Adds Indica Lab’s HALO and HyperCluster Platform to Increase its Histopathology Image Analysis Service Capabilities

| January 26, 2016 | 0 Comments

OracleBio, a leading provider of high quality precision histopathology image analysis services to support pre-clinical and clinical pharmaceutical R&D, is pleased to announce that it has incorporated Indica Lab’s HALO™ plus Hyper-Cluster™ platform as part of its image analysis service capabilities. OracleBio’s Chief Scientific Officer, Dr Lorcan Sherry, commented: “We have experienced a significant upturn […]

Continue Reading

Pathcore Selected by National Cancer Institute to Enable Cancer Informatics Development

| January 25, 2016 | 0 Comments

$2.92M Investment by NCI Will Lead to Validated Clinical Cancer Diagnostic Algorithms Using Pathcore’s Technologies TORONTO — Pathcore™ and a team of investigators from the US and Canada have received an award from the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), to develop a pathology informatics platform. This will allow researchers to […]

Continue Reading

Defending your lab against recoupments, repayment demands, and SIU audits

| January 21, 2016 | 0 Comments

Recent federal case law has determined that a recoupment is an adverse benefit determination, which means it falls under ERISA. Now, when your laboratory is hit with a recoupment or repayment demand, you have the right to an appeal, and to a review of that appeal. Insurers must give you the reasons behind their repayment demands—and allow you to challenge them.

Continue Reading

UPMC Chooses PathXL for Digital Pathology Education

| January 21, 2016 | 0 Comments

PathXL software to provide UPMC with an end to end solution for institution wide digital pathology education program Belfast, Northern Ireland, January 21, 2016 — PathXL is proud to have been selected by UPMC (Pittsburgh, USA) as the software provider for digital pathology training and examinations across the institution. UPMC is a leading, integrated healthcare provider […]

Continue Reading

Check Out PathVision from Faxitron

| January 20, 2016 | 0 Comments

Faxitron is the industry standard in cabinet x-ray systems for point-of-care specimen radiography, research imaging irradiation and NDT applications. Their install base exceeds more than 7,000 systems worldwide in medical and scientific facilities. I was first introduced to Faxitron at CAP ’14 year before last in Chicago and was impressed by the technology and enhancements […]

Continue Reading

Flagship Biosciences Creates Clinical Trials and Regulatory Affairs Group

| January 20, 2016 | 0 Comments

Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – January 19th, 2016 – Flagship Biosciences has created a Clinical Trials and Regulatory Affairs group and partners […]

Continue Reading

Register Today for The International Symposium for Tissue Phenomics®

| January 18, 2016 | 0 Comments

Definiens invites you to attend The International Symposium for Tissue Phenomics, happening April 26-27, 2016 in Cambridge, Massachusetts. Enjoy expert presentations on immuno-oncology and big data, valuable panel discussions, all while networking with your peers and other industry experts. Hear speakers from cutting edge organizations such as: Charite INSERM MD Anderson Merck MedImmune MIT NIH Providence […]

Continue Reading

Omnyx Applauds FDA and Digital Pathology Association on Recent Collaboration 

| January 17, 2016 | 0 Comments

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been classified, and for which there is no predicate device (as in whole slide imaging systems). If the FDA […]

Continue Reading

DPA Recommends Whole Slide Imaging Manufacturers Submit De Novo Applications to the FDA for Primary Diagnosis

| January 14, 2016 | 0 Comments

Collaboration with FDA Results in Opportunity for Streamlined Approval Process The Digital Pathology Association (DPA) announced today that it suggests digital pathology manufacturers currently interested in marketing whole slide imaging (WSI) devices for primary diagnosis in the United States submit de novo applications to the Food and Drug Administration (FDA). WSI is a technology which […]

Continue Reading

Doc the Bartender

| January 14, 2016 | 0 Comments

Many thanks to Dr. Jordan Grumet at In My Humble Opinion for allowing me to repost this recent article he shared. I have mentioned Jordan before and appreciate his very personal thoughts he shares with great style and prose.  Many of his frustrations in his practice are not necessarily pain points for pathologists but I think this post […]

Continue Reading

Man on The Moon

| January 13, 2016 | 0 Comments

I don’t usually make political statements on this blog and don’t plan on doing so anytime soon. In fact, I have little interest at the moment and 2-year presidential election cycles and endless coverage of every detail of the professional and personal lives of candidates and elected officials. Having said that, I watched the State […]

Continue Reading